Last updated: October 24, 2026
External links and commercial relationships
Kapitalshare links to external financial providers and platforms. Any commercial relationship must be disclosed clearly next to the relevant link, before a visitor clicks.
Confirm the legal entity and authorisation for your country, read current costs and product documents, and understand whether you are investing in securities or trading leveraged products.
Broker and partner links
The project includes links to PU Prime and Trade Republic. The available project information does not establish the current agreement, whether compensation is paid, how it is calculated, or which legal entity receives it.
- PU Prime: [Operator: confirm whether this is an affiliate, partner, advertising or ordinary link. State any compensation and relevant provider entity.]
- Trade Republic: [Operator: provide the same details for this referral link.]
Until the arrangements are verified, the site must not claim that compensation is or is not received. Add a clear, accurate disclosure beside each link before publication, and update it if the relationship changes. Disclosure does not remove licensing, commission-ban, advertising or investment-recommendation obligations.
No recommendation
An external link does not mean that Kapitalshare recommends or considers suitable any provider, account, instrument or strategy. Providers set their own eligibility rules, products, costs and protections. Check registrations and warnings with the relevant regulator. The AFM provider check is a starting point for the Netherlands.
Risks
Investing can result in losses. CFDs, forex and leveraged products can cause substantial losses quickly. Check whether a provider is authorised to offer its service in your country and review the investor protections that apply.
Transparency around recommendations
If a publication contains an explicit or implied view on buying, selling, portfolio construction or price, rules for investment recommendations may apply. Clearly identify facts, interpretations and interests, cite sources and publication times where required, and keep recommendations current and careful. See the ESMA guidance and AFM guidance.
Questions or corrections: [enter provider contact details].